Range Bio: Range Biotechnologies: Proteomics-Focused Biotech Company Completes $5.2 Million Seed Funding Round

Range Biotechnologies - a proteomics-focused biotech company that has developed an innovative translational platform to enable better diagnostics and faster drug development - announced recently that it has received $5.2 million in seed funding led by TechBio-focused ARTIS Ventures with additional participation from Pear VC, Page One Ventures, Civilization Ventures, Pillar, Four Cities Capital, Hawktail, and several others. The post Range Biotechnologies: Proteomics-Focused Biotech Company Completes $5.2 Million Seed Funding Round appeared first on Pulse 2.0.